Clinical Trials Logo

Clinical Trial Summary

This study is intended to evaluate the efficiency of utilizing "dynamic implant valve approach" (DIVA) system in treating chronic maxillary sinusitis.


Clinical Trial Description

A prospective study aimed to test the efficiency of a minimal interventional approach in treating chronic maxillary sinusitis. The "dynamic implant valve approach" (DIVA), a minimally invasive approach utilizes a dental implant, designed with an internal sealing screw that might serve as drug delivery system via its channel. The implant is inserted to a posterior maxillary edentulous area, creating a connection between the sinus cavity and the oral cavity (Oro-antral connection), hence, provides a controlled working channel for diagnosis and treatment of the disease (e.g; allowing drainage, lavage and sinus endoscopy). The implant is a medical device approved for use at the anatomical area of interest.

The treatment method proposed in this study is based on the principle of a conventional treatment of washing the maxillary sinus cavity called "Antral puncture and lavage".

The changes that are proposed in this study could make the operation more convenient and effective in the therapeutic level, both for the patient and the clinician for the following reasons:

- DIVA (Dynamic Implant Valve Approach) Implant with a multi- useful working channel: the mere presence of the canal in the center of the implant with a screw seal, ensures controlled Oro-antral connection, and enables multiple endoscopy and lavage procedures until resolution of the pathological condition is achieved.

- The anatomical location of the puncture / penetration to the sinus - is performed in the maxillary edentulous region. This is the lowest area of the sinus cavity (standing or sitting posture), which utilizes gravity for drainage and extraction of the contaminated contents of the sinus.

By appropriate advance planning, the implant, after eradication of the disease, can later be used for prosthetic purposes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03083392
Study type Interventional
Source Western Galilee Hospital-Nahariya
Contact Ruth Angel-Dar, Dr.
Phone +972-4-9107076
Email rutiangel123@gmail.com
Status Not yet recruiting
Phase N/A
Start date March 2017
Completion date March 2019

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04903418 - Assessment of Relationship Between Maxillary Sinus Floor and Maxillary Posterior Teeth Root Tips Position
Completed NCT00683371 - Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis N/A
Completed NCT00236652 - A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days. Phase 3
Recruiting NCT06130176 - Single-step Functional Sinus Endoscopy and Transoral Surgery N/A
Recruiting NCT04241016 - Endoscopic Sinus Surgery in Recurrent Acute Rhinosinusitis N/A
Completed NCT00668304 - Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox Phase 4
Recruiting NCT04645511 - Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis. N/A
Not yet recruiting NCT02931604 - Study Designed to Clinically Evaluate Sinus Wash Device Prototypes N/A
Completed NCT00643409 - A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults Phase 3
Terminated NCT00245440 - Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis Phase 4
Completed NCT00537563 - AMS VS MOXI Ketek vs Avelox in AMS Phase 3
Completed NCT00249210 - A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses Phase 3
Completed NCT01032174 - Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis N/A